(BROS) Dutch Bros - Overview
Stock: Coffee, Energy Drink, Smoothies, Shakes
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 58.5% |
| Relative Tail Risk | -16.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.04 |
| Alpha | -36.70 |
| Character TTM | |
|---|---|
| Beta | 1.682 |
| Beta Downside | 1.730 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.17% |
| CAGR/Max DD | 0.35 |
Description: BROS Dutch Bros January 03, 2026
Dutch Bros Inc. (NYSE:BROS) operates a network of drive-thru coffee shops across the United States, split between Company-Operated Shops and franchised locations. The brand portfolio includes Dutch Bros, Dutch Bros Coffee, Dutch Bros Rebel, and Blue Rebel, all sold primarily through physical drive-thru outlets and online ordering channels.
Founded in 1992 and headquartered in Grants Pass, Oregon, the company reported FY 2023 revenue of approximately $1.5 billion and grew its store count to roughly 800 locations, with franchisees now accounting for about 30 percent of total outlets. Same-store sales rose ~15 percent year-over-year, driven by higher average ticket size (≈ $7.20) and strong demand for the higher-margin Rebel energy-drink line.
Key economic drivers for Dutch Bros include discretionary consumer spending trends, coffee bean price volatility, and labor-cost inflation-factors that disproportionately affect drive-thru concepts with lower overhead than full-service cafés. At the sector level, the continued shift toward on-the-go coffee consumption and the expansion of franchise models are boosting scalability and cash-flow generation for players like Dutch Bros.
For a deeper, data-rich analysis of Dutch Bros’ valuation and scenario modeling, consult the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 62.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 2.67 > 1.0 |
| NWC/Revenue: 7.59% < 20% (prev 13.55%; Δ -5.96% < -1%) |
| CFO/TA 0.10 > 3% & CFO 278.1m > Net Income 62.1m |
| Net Debt (769.4m) to EBITDA (239.2m): 3.22 < 3 |
| Current Ratio: 1.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.4m) vs 12m ago 11.49% < -2% |
| Gross Margin: 26.33% > 18% (prev 0.26%; Δ 2607 % > 0.5%) |
| Asset Turnover: 57.43% > 50% (prev 49.04%; Δ 8.40% > 0%) |
| Interest Coverage Ratio: 5.09 > 6 (EBITDA TTM 239.2m / Interest Expense TTM 27.4m) |
Altman Z'' 0.74
| A: 0.04 (Total Current Assets 341.1m - Total Current Liabilities 224.5m) / Total Assets 2.92b |
| B: 0.03 (Retained Earnings 78.1m / Total Assets 2.92b) |
| C: 0.05 (EBIT TTM 139.3m / Avg Total Assets 2.68b) |
| D: 0.04 (Book Value of Equity 78.3m / Total Liabilities 2.06b) |
| Altman-Z'' Score: 0.74 = B |
Beneish M -2.79
| DSRI: 1.07 (Receivables 14.3m/10.4m, Revenue 1.54b/1.19b) |
| GMI: 0.99 (GM 26.33% / 26.10%) |
| AQI: 1.09 (AQ_t 0.34 / AQ_t-1 0.31) |
| SGI: 1.29 (Revenue 1.54b / 1.19b) |
| TATA: -0.07 (NI 62.1m - CFO 278.1m) / TA 2.92b) |
| Beneish M-Score: -2.79 (Cap -4..+1) = A |
What is the price of BROS shares?
Over the past week, the price has changed by +4.87%, over one month by -9.83%, over three months by +7.18% and over the past year by -15.81%.
Is BROS a buy, sell or hold?
- StrongBuy: 10
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BROS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.1 | 35.2% |
| Analysts Target Price | 77.1 | 35.2% |
| ValueRay Target Price | 58.2 | 2% |
BROS Fundamental Data Overview February 03, 2026
P/E Forward = 64.5161
P/S = 5.8231
P/B = 11.1194
Revenue TTM = 1.54b USD
EBIT TTM = 139.3m USD
EBITDA TTM = 239.2m USD
Long Term Debt = 196.0m USD (from longTermDebt, last quarter)
Short Term Debt = 36.5m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 769.4m USD (from netDebt column, last quarter)
Enterprise Value = 9.72b USD (8.95b + Debt 1.04b - CCE 267.2m)
Interest Coverage Ratio = 5.09 (Ebit TTM 139.3m / Interest Expense TTM 27.4m)
EV/FCF = 148.6x (Enterprise Value 9.72b / FCF TTM 65.4m)
FCF Yield = 0.67% (FCF TTM 65.4m / Enterprise Value 9.72b)
FCF Margin = 4.25% (FCF TTM 65.4m / Revenue TTM 1.54b)
Net Margin = 4.04% (Net Income TTM 62.1m / Revenue TTM 1.54b)
Gross Margin = 26.33% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 25.21% (prev 28.87%)
Tobins Q-Ratio = 3.33 (Enterprise Value 9.72b / Total Assets 2.92b)
Interest Expense / Debt = 0.65% (Interest Expense 6.70m / Debt 1.04b)
Taxrate = 21.92% (7.66m / 34.9m)
NOPAT = 108.8m (EBIT 139.3m * (1 - 21.92%))
Current Ratio = 1.52 (Total Current Assets 341.1m / Total Current Liabilities 224.5m)
Debt / Equity = 1.58 (Debt 1.04b / totalStockholderEquity, last quarter 656.6m)
Debt / EBITDA = 3.22 (Net Debt 769.4m / EBITDA 239.2m)
Debt / FCF = 11.76 (Net Debt 769.4m / FCF TTM 65.4m)
Total Stockholder Equity = 607.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.32% (Net Income 62.1m / Total Assets 2.92b)
RoE = 10.22% (Net Income TTM 62.1m / Total Stockholder Equity 607.3m)
RoCE = 17.34% (EBIT 139.3m / Capital Employed (Equity 607.3m + L.T.Debt 196.0m))
RoIC = 12.99% (NOPAT 108.8m / Invested Capital 837.6m)
WACC = 10.91% (E(8.95b)/V(9.99b) * Re(12.11%) + D(1.04b)/V(9.99b) * Rd(0.65%) * (1-Tc(0.22)))
Discount Rate = 12.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.01%
[DCF Debug] Terminal Value 58.38% ; FCFF base≈65.4m ; Y1≈42.9m ; Y5≈19.6m
Fair Price DCF = N/A (negative equity: EV 257.1m - Net Debt 769.4m = -512.3m; debt exceeds intrinsic value)
EPS Correlation: 49.04 | EPS CAGR: 8.38% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.30 | Revenue CAGR: 34.32% | SUE: 1.31 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.18 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=17
EPS next Year (2026-12-31): EPS=0.88 | Chg30d=-0.018 | Revisions Net=-4 | Growth EPS=+31.3% | Growth Revenue=+25.6%